{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T10:41:47Z","timestamp":1785408107003,"version":"3.56.0"},"posted":{"date-parts":[[2026,1,15]]},"group-title":"Bioengineering","reference-count":49,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"award":["R01EB026893"],"award-info":[{"award-number":["R01EB026893"]}],"id":[{"id":"https:\/\/ror.org\/00372qc85","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,4,13]]},"abstract":"<jats:p>\n                  Precise control of genome editing activity in vivo remains a major barrier to the clinical translation of CRISPR-based therapeutics, as current approaches cannot reliably restrict editing activity to target tissues\n                  <jats:sup>1,2,3<\/jats:sup>\n                  . Here we show that a magnetically gated baculoviral CRISPR platform enables spatial control of genome editing activity\n                  <jats:sup>4<\/jats:sup>\n                  . By coupling magnetic activation of viral transduction at target sites with complement-mediated inactivation of circulating vectors, this system functionally confines genome editing activity to defined spatial contexts, effectively decoupling editing activity from biodistribution. We further show that spatially confined genome editing can be coupled with endogenous antiviral sensing to drive coordinated immune modulation within tumours. In a syngeneic murine tumour model, local administration combined with magnetic activation restricts genome editing to tumours without detectable editing in major organs, remodels dendritic cell and CD8\u25a1 T cell states, suppresses tumour growth, and extends survival. Together, these findings establish a generalizable strategy for spatial control of genome editing and localized immunomodulation in cancer.\n                <\/jats:p>","DOI":"10.64898\/2026.01.14.699490","type":"posted-content","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T18:10:18Z","timestamp":1768500618000},"source":"Crossref","is-referenced-by-count":0,"title":["Spatial control of genome editing activity enables localized immunotherapy"],"prefix":"10.64898","author":[{"given":"Xiaoyue","family":"Yang","sequence":"first","affiliation":[{"name":"F. Joseph Halcomb III, M.D. Department of Biomedical Engineering, University of Kentucky, Lexington, Kentucky 40536, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Tong","sequence":"additional","affiliation":[{"name":"Department of Bioengineering, Stanford University, Stanford, California 94305, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidan","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Huang","sequence":"additional","affiliation":[{"name":"College of Medicine, University of Kentucky, Lexington, Kentucky, 40536, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongchao","family":"Yi","sequence":"additional","affiliation":[{"name":"F. Joseph Halcomb III, M.D. Department of Biomedical Engineering, University of Kentucky, Lexington, Kentucky 40536, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daheng","family":"He","sequence":"additional","affiliation":[{"name":"Division of Cancer Biostatistics, Department of Internal Medicine, University of Kentucky, Lexington, Kentucky 40536, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingpeng","family":"Liu","sequence":"additional","affiliation":[{"name":"Division of Cancer Biostatistics, Department of Internal Medicine, University of Kentucky, Lexington, Kentucky 40536, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Cancer Biostatistics, Department of Internal Medicine, University of Kentucky, Lexington, Kentucky 40536, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liang","sequence":"additional","affiliation":[{"name":"New York Blood Center, New York, New York 10065, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8632-7933","authenticated-orcid":false,"given":"Sheng","family":"Tong","sequence":"additional","affiliation":[{"name":"F. Joseph Halcomb III, M.D. Department of Biomedical Engineering, University of Kentucky, Lexington, Kentucky 40536, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2026041601301782000_2026.01.14.699490v4.1","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/s41578-019-0145-9","article-title":"Engineered materials for in vivo delivery of genome-editing machinery","volume":"4","year":"2019","journal-title":"Nat Rev Mater"},{"key":"2026041601301782000_2026.01.14.699490v4.2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-1978-5"},{"key":"2026041601301782000_2026.01.14.699490v4.3","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-023-00762-x"},{"key":"2026041601301782000_2026.01.14.699490v4.4","first-page":"126","article-title":"Spatial control of in vivo CRISPR-Cas9 genome editing via nanomagnets","volume":"3","year":"2019","journal-title":"Nat Biomed Eng"},{"key":"2026041601301782000_2026.01.14.699490v4.5","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","year":"2021","journal-title":"Nat Rev Mater"},{"key":"2026041601301782000_2026.01.14.699490v4.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2016.07.006"},{"key":"2026041601301782000_2026.01.14.699490v4.7","doi-asserted-by":"publisher","DOI":"10.1089\/104303403321467199"},{"key":"2026041601301782000_2026.01.14.699490v4.8","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.2623"},{"key":"2026041601301782000_2026.01.14.699490v4.9","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.2647"},{"key":"2026041601301782000_2026.01.14.699490v4.10","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gku402"},{"key":"2026041601301782000_2026.01.14.699490v4.11","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2012.286"},{"key":"2026041601301782000_2026.01.14.699490v4.12","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1095"},{"key":"2026041601301782000_2026.01.14.699490v4.13","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11529"},{"key":"2026041601301782000_2026.01.14.699490v4.14","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3300607"},{"key":"2026041601301782000_2026.01.14.699490v4.15","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0218-4"},{"key":"2026041601301782000_2026.01.14.699490v4.16","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2016.2"},{"key":"2026041601301782000_2026.01.14.699490v4.17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1414428"},{"key":"2026041601301782000_2026.01.14.699490v4.18","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2015.209"},{"key":"2026041601301782000_2026.01.14.699490v4.19","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-009063"},{"key":"2026041601301782000_2026.01.14.699490v4.20","unstructured":"Samson, A. et al. Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade. Sci Transl Med 10 (2018)."},{"key":"2026041601301782000_2026.01.14.699490v4.21","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1016\/j.celrep.2019.11.113","article-title":"Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression","volume":"29","year":"2019","journal-title":"Cell Rep"},{"key":"2026041601301782000_2026.01.14.699490v4.22","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1038\/s41467-020-17011-z","article-title":"Oncolytic virus-derived type I interferon restricts CAR T cell therapy","volume":"11","year":"2020","journal-title":"Nat Commun"},{"key":"2026041601301782000_2026.01.14.699490v4.23","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.5.2847-2858.2005"},{"key":"2026041601301782000_2026.01.14.699490v4.24","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mt.6300008"},{"key":"2026041601301782000_2026.01.14.699490v4.25","first-page":"4686","article-title":"Clinical experiences with magnetic drug targeting: a phase I study with 4\u2019-epidoxorubicin in 14 patients with advanced solid tumors","volume":"56","year":"1996","journal-title":"Cancer Res"},{"key":"2026041601301782000_2026.01.14.699490v4.26","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1148\/radiol.2301021493","article-title":"Hepatocellular carcinoma: regional therapy with a magnetic targeted carrier bound to doxorubicin in a dual MR imaging\/ conventional angiography suite--initial experience with four patients","volume":"230","year":"2004","journal-title":"Radiology"},{"key":"2026041601301782000_2026.01.14.699490v4.27","doi-asserted-by":"crossref","first-page":"6785","DOI":"10.1021\/acsanm.0c01193","article-title":"Lipid-Encapsulated Fe3O4 Nanoparticles for Multimodal Magnetic Resonance\/Fluorescence Imaging","volume":"3","year":"2020","journal-title":"Acs Appl Nano Mater"},{"key":"2026041601301782000_2026.01.14.699490v4.28","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-020-0850-8"},{"key":"2026041601301782000_2026.01.14.699490v4.29","doi-asserted-by":"crossref","first-page":"8009","DOI":"10.1038\/ncomms9009","article-title":"Directing cell therapy to anatomic target sites in vivo with magnetic resonance targeting","volume":"6","year":"2015","journal-title":"Nat Commun"},{"key":"2026041601301782000_2026.01.14.699490v4.30","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.1002\/adma.201200221","article-title":"X-space MPI: magnetic nanoparticles for safe medical imaging","volume":"24","year":"2012","journal-title":"Adv Mater"},{"key":"2026041601301782000_2026.01.14.699490v4.31","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3003594"},{"key":"2026041601301782000_2026.01.14.699490v4.32","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.6.2348"},{"key":"2026041601301782000_2026.01.14.699490v4.33","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-7799(01)01911-4"},{"key":"2026041601301782000_2026.01.14.699490v4.34","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06623-2"},{"key":"2026041601301782000_2026.01.14.699490v4.35","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2009.135"},{"key":"2026041601301782000_2026.01.14.699490v4.36","doi-asserted-by":"crossref","unstructured":"Rivera-Orellana, S. et al. Oncolytic virotherapy and tumor microenvironment modulation. Clin Exp Med 25, 256 (2025).","DOI":"10.1007\/s10238-025-01691-2"},{"key":"2026041601301782000_2026.01.14.699490v4.37","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2016.151"},{"key":"2026041601301782000_2026.01.14.699490v4.38","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3155"},{"key":"2026041601301782000_2026.01.14.699490v4.39","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3245"},{"key":"2026041601301782000_2026.01.14.699490v4.40","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01897-x"},{"key":"2026041601301782000_2026.01.14.699490v4.41","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1021\/nl201978c","article-title":"Self-assembly of phospholipid-PEG coating on nanoparticles through dual solvent exchange","volume":"11","year":"2011","journal-title":"Nano Lett"},{"key":"2026041601301782000_2026.01.14.699490v4.42","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky354"},{"key":"2026041601301782000_2026.01.14.699490v4.43","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-019-0032-3"},{"key":"2026041601301782000_2026.01.14.699490v4.44","doi-asserted-by":"crossref","first-page":"15594","DOI":"10.1038\/ncomms15594","article-title":"Magnetic forces enable controlled drug delivery by disrupting endothelial cell-cell junctions","volume":"8","year":"2017","journal-title":"Nat Commun"},{"key":"2026041601301782000_2026.01.14.699490v4.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.08.069"},{"key":"2026041601301782000_2026.01.14.699490v4.46","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.05.031"},{"key":"2026041601301782000_2026.01.14.699490v4.47","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-019-0619-0"},{"key":"2026041601301782000_2026.01.14.699490v4.48","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.73600.2"},{"key":"2026041601301782000_2026.01.14.699490v4.49","doi-asserted-by":"publisher","DOI":"10.1038\/s41596-024-01020-z"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.01.14.699490","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T08:30:25Z","timestamp":1776328225000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.64898\/2026.01.14.699490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,15]]},"references-count":49,"URL":"https:\/\/doi.org\/10.64898\/2026.01.14.699490","relation":{},"subject":[],"published":{"date-parts":[[2026,1,15]]},"subtype":"preprint"}}